Form 4 holding
Chief Business Officer
Aurinia Pharmaceuticals Inc.
- Security class
- Common Stock
- Shares / value
- 259,162
- Estimated value
- $2,918,164
- Report date
- 02 Mar 2023
- Price
- $11.26
- Ownership
- Direct
Michael Robert Martin
Insider Reports History
- Reporting-owner location
- Victoria, British Columbia, Canada
- Latest reporting-owner signature
-
/s/ Stephen Robertson, Attorney-in-Fact for Michael Robert Martin
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Michael Robert Martin
Insider Reports Filed by Michael Robert Martin
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 02 Mar 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 06 Mar 2023, 15:28
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 07 Nov 2022
- Transactions
- 1
- Transaction value
- +$154,800
- Accepted by SEC
- 09 Nov 2022, 15:05
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 02 Mar 2022
- Transactions
- 4
- Transaction value
- -$58,236
- Accepted by SEC
- 04 Mar 2022, 15:13
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 09 Nov 2021
- Transactions
- 7
- Transaction value
- -$4,004,260
- Accepted by SEC
- 12 Nov 2021, 15:18
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 01 Nov 2021
- Transactions
- 3
- Transaction value
- -$1,279,800
- Accepted by SEC
- 03 Nov 2021, 16:20
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 20 Sep 2021
- Transactions
- 11
- Transaction value
- -$2,070,975
- Accepted by SEC
- 22 Sep 2021, 16:31
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 14 Sep 2021
- Transactions
- 4
- Transaction value
- -$725,020
- Accepted by SEC
- 16 Sep 2021, 17:01
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 10 Sep 2021
- Transactions
- 8
- Transaction value
- -$1,887,217
- Accepted by SEC
- 14 Sep 2021, 18:16
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 07 Sep 2021
- Transactions
- 1
- Transaction value
- -$135,750
- Accepted by SEC
- 08 Sep 2021, 16:04
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 26 Aug 2021
- Transactions
- 1
- Transaction value
- -$400,725
- Accepted by SEC
- 27 Aug 2021, 16:09
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 09 Aug 2021
- Transactions
- 1
- Transaction value
- -$80,050
- Accepted by SEC
- 10 Aug 2021, 16:09
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 28 Jul 2021
- Transactions
- 1
- Transaction value
- -$69,300
- Accepted by SEC
- 29 Jul 2021, 16:09
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 22 Jun 2021
- Transactions
- 1
- Transaction value
- -$68,800
- Accepted by SEC
- 23 Jun 2021, 16:06
- Role
- Chief Business Officer
- Next action
- Open filing details
4
AUPH
Aurinia Pharmaceuticals Inc.
- Report period
- 11 May 2021
- Transactions
- 2
- Transaction value
- +$60,400
- Accepted by SEC
- 12 May 2021, 16:30
- Role
- Chief Business Officer
- Next action
- Open filing details